About Wesper
Wesper is a company based in New York (United States) founded in 2017. It operates as a Product-as-a-Service, Direct-to-Consumer (D2C), and HealthTech. Wesper has raised $49.64 million across 5 funding rounds from investors including Valor Equity Partners, Breyer Capital and Spark Capital. Wesper offers products and services including Wesper Home Sleep Test, Wesper Wellness Program, and GLP-1 Therapy with Wesper. Wesper operates in a competitive market with competitors including Oura, Biotricity, SleepScore Labs, Jawbone and Sleep Number, among others.
- Headquarter New York, United States
-
Sectors
RetailTechnology Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$49.64 M (USD)
in 5 rounds
-
Latest Funding Round
$17.89 M (USD), Series B
Aug 10, 2026
-
Investors
Valor Equity Partners
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Wesper
Wesper offers a comprehensive portfolio of products and services, including Wesper Home Sleep Test, Wesper Wellness Program, and GLP-1 Therapy with Wesper.
Home sleep test is provided for accurate diagnostics.
Sleep wellness program is offered for individual care.
GLP-1 therapy is integrated for sleep apnea treatment.
People of Wesper
Unlock access to complete
Unlock access to complete
Funding Insights of Wesper
Wesper has successfully raised a total of $49.64M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $17.89 million completed in August 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Wesper
Wesper has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Valor Equity Partners, Breyer Capital and Spark Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Locked | Locked | Locked | |
|
Venture capital firm
|
Locked | Locked | Locked | |
|
Spark Capital is engaged in venture capital investments.
|
Locked | Locked | Locked |
Investor details for Wesper
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wesper
Investment portfolio details for Wesper
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Wesper
Detailed financials for Wesper
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wesper Comparisons
Peer comparison for Wesper
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wesper
Wesper operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oura, Biotricity, SleepScore Labs, Jawbone and Sleep Number, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
Sleep quality is monitored via bedside devices and mobile apps.
|
|
| Locked | Locked | Locked |
Provider of wearable devices for activity and sleep tracking
|
|
| Locked | Locked | Locked |
Smart beds and sleep technology are provided for personalized wellness.
|
|
| Locked | Locked | Locked |
Home sleep testing for obstructive sleep apnea is offered.
|
Detailed competitors of Wesper
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wesper
Complete news archive for Wesper
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wesper
Wesper was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Wesper is headquartered in New York, United States. It is registered at New York, New York, United States.
Amir Reuveny is the current CEO of Wesper.
Wesper is a funded company, having raised a total of $49.64M across 5 funding rounds to date.
Wesper is engaged in delivering advanced sleep diagnostic tools and wellness programs. Solutions are offered for both individuals and healthcare professionals, including hospitals and clinics. Home sleep apnea tests with clinical-grade data are provided, featuring wearable devices for comfort and convenience. Sectors such as bariatric, cardiology, and pulmonology are served with tailored insights. GLP-1 therapy integration is also included to address sleep apnea treatment needs.
Wesper's top competitors include Oura, Jawbone and Biotricity.
Wesper offers Wesper Home Sleep Test, Wesper Wellness Program, and GLP-1 Therapy with Wesper.
Wesper has 3 investors. Key investors include Valor Equity Partners, Breyer Capital, and Spark Capital.